Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas

Cancer Research

Volumn 59, Issue 19, 1999, Pages 4876-4881

  Sauter, Edward R ^a   Nesbit, Mark ^a   Litwin, Samuel ^b   Klein Szanto, Andres J P ^b   Cheffetz, Susan ^a   Herlyn, Meenhard ^a  

^a WISTAR INSTITUTE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN D1;

ADENOVIRUS 5; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; GENETIC TRANSDUCTION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

ADENOVIRUSES, HUMAN; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL DIVISION; CYCLIN D1; DNA, ANTISENSE; FEMALE; GENE AMPLIFICATION; GENETIC VECTORS; HEAD AND NECK NEOPLASMS; HUMANS; OPEN READING FRAMES; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 0033215232     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Helin, K., and Harlow, E. The retinoblastoma protein as a transcriptional repressor. Trends Cell Biol., 3: 43-46, 1992.
2. Goodrich, D. W., and Lee, W-H. Molecular characterization of the retinoblastoma susceptibility gene. Biochim. Biophys. Acta, 1155: 43-61, 1993.
3. Nevins, J. R. E2F; a link between the Rb tumor suppressor protein and viral oncogenesis. Science (Washington DC), 258: 4249, 1992.
4. Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., and Weinberg, R. A. Physical interaction of the retinoblastoma protein and mammalian D-type cyclins. Cell, 73: 487-497, 1993.
5. Xu, L., Davidson, B. J., Murty, V. V., Li, R. G., Sacks, P. G., Garin-Chesa, P., Schantz, P., and Chaganti, R. S. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines. Int. J. Cancer, 59: 383-387, 1994.
6. Matsushime, H. D., Quelle, E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., and Kato. J. Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell Biol., 14: 2066-2076, 1994.
7. INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells. Oncogene, 16: 265-272, 1998.
8. 1. J. Cell Biol., 125: 625-638, 1994.
9. Jin, Y., Higashi, K., Mandahl, N., Heim, S., Wennerberg, J., Biorklund, A., Dictor, M., and Mitelman, F. Frequent rearrangement of chromosomal bands 1p22 and 11q13 in squamous cell carcinomas of the head and neck. Genes Chromosomes Cancer, 1: 198-204, 1990.
10. Leonard, J. H., Keansley, J. H., Cherevix-Trench, G., and Hayward, N. K. Analysis of gene amplification in head and neck squamous cell carcinomas. Int. J. Cancer, 48: 511-515, 1991.
11. 1 regulation in human head and neck cancer. Cancer Res., 55: 949-956, 1995.
12. Adelaide, J., Monges, G., Derderian, C., Seitz, J. F., and Birnbaum, D. Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. Br. J. Cancer, 71: 64-68, 1995.
13. 1 phase in rodent fibroblasts. Genes Dev., 7: 1559-1571, 1993.
14. Jiang, W., Kahn, S. M., Zhow, P., Zhang, Y. J., Cacace, A. M., Infante, A. S., Doi, S., Santella, R. M., and Weinstein, I. B. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression, and gene expression. Oncogene, 8: 3447-3457, 1993.
15. Hinds, P. W., Dowdy, S. F., Eaton, E. N., Arnold, A., and Weinberg, R. A. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA, 91: 709-713, 1994.
16. Lovec, H., Sewing, A., Lucibello, F. C., Muller, R., and Moroy, T. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene, 9: 323-326, 1994.
17. Mueller, A., Odze, R., Jenkins, T. D., Shahsesfaei, A., Nakagawa, H., Inomoto, T., and Rustgi, A. K. A transgenic mouse model with cyclin D1 overexpression results in cell cycle, epidermal growth factor receptor, and p53 abnormalities. Cancer Res., 57: 5542-5549, 1997.
18. Palermo, I., and Peters, G. Perturbation of cell cycle regulators in human cancer. Cancer Surv., 27: 351-367, 1996.
19. Waber, P., Dlugosz, S., Cheng, Q. C., Truelson, J., and Nisen, P. D. Genetic alterations of chromosome band 9p12-22 in head and neck. Oncogene, 15: 1699-1704, 1997.
20. Gonzalez, M. V., Pello, M. F., Lopez-Larrea, C., Suarez, C., Menendez, M. J., and Coto, E. Deletion and methylation of the tumour suppressor gene p16/CDKN2 in primary head and neck squamous cell carcinoma. J. Clin. Pathol., 50: 509-512, 1997.
21. Busatto, G., Shiao, Y. H., Parenti, A. R., Baffa, R., Ruol, A., Piebani, M., and Rugge, M. p16/CDKN2 alterations and pRb expression in oesophageal squamous carcinoma. Mol. Pathol., 51: 80-84, 1998.
22. El-Naggar, A. K., Lai, S., Clayman, G., Lee, J. K., Luna, M. A., Goepfert, H., and Batsakis, J. G. Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. Am. J. Pathol., 151: 1767-1774, 1997.
23. Soufir, N., Avril, M. F., Chompret, A., Demenais, F., Bombled, J., Spatz, A., Stoppa-Lyonnet, D., Benard, J., and Bressac-de Paillerets, B. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. Hum. Mol. Genet., 7: 209-216, 1998.
24. Graham, F. L., Smiley, J., Russell, W. C., and Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol., 36: 59-74, 1977.
25. Satyamoorthy, K., Nesbit, M., Hsu, M-Y., and Herlyn, M. Utility of adenoviruses as gene expression modules in melanoma. In: M. Maio (ed.), Immunology of Human Melanoma, pp. 71-77. Amsterdam, the Netherlands: IOS Press, 1996.
26. Ranheim, T. S., Shisler, J., Horton, T. M., Wold, L. J., Gooding, L. R., and Wold, W. S. Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor. J. Virol., 67: 2159-2167, 1993.
27. Hurt, B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol., 26: 365-369, 1997.
28. Rosenfeld, M. A., Siegfried, W., Yoshimura, K., Yoneyama, K., Fukayama, M., Stier, L. E., Paakko, P. K., Gilardi, P., Stratford-Perricaudet, L. D., Perricaudet, M., Jallat, S., Paviran, A., Lecocq, J. P., and Crystal, R. G. Adenovirus-mediated transfer of a recombinant αl-antitrypsin gene to the lung epithelium in vivo. Science (Washington DC), 252: 431-434, 1991.
29. Graham, F. L., and Eb, A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 52: 456-467, 1973.
30. Cagnoli, M., Barbieri, F., Bruzzo, C., and Alma, A. Control of cyclin D1 expression by antisense oligonucleotides in three ovarian cancer cell lines. Gynecol. Oncol., 70: 372-377, 1998.
31. INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells. Oncogene, 16: 265-272, 1998.
32. Liu, T. J., Zhang, W. W., Taylor, D. L., Roth, J. A., Goepfert, H., and Clayman, G. L. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res., 54: 3662-3667, 1994.
33. Hamada, K., Alemany, R., Zhang, W. W., Hittelman, W. N., Lotan, R., Roth, J. A., and Mitchell, M. F. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer. Cancer Res., 56: 3047-3054, 1996.
34. Wersto, R. P., Rosenthal, E. R., Seth, P. K., Eissa, N. T., and Donahue, R. E. Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins. J. Virol., 72: 9491-9502, 1998.
35. Hung, W-C., Huang, J-S., and Chuang, L-Y. Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression. Biochem. Biophys. Res. Commun., 220: 719-723, 1996.
36. Schrump, D. S., Chen, A., and Consoli, U. Inhibition of lung cancer proliferation by antisense cyclin D. Cancer Gene Ther., 3: 131-135, 1996.
37. Driscoll, B., Wu, L., Buckley, S., Hall, F. L., Anderson, K. D., and Warburton, D. Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth. Am. J. Physiol., 273: L941-L949, 1997.
38. Wang, M. B., Billings, K. R., Venkatesan, N., Hall, F. L., and Srivatsan, E. S. Inhibition of cell proliferation in head and neck squamous cell carcinoma cell lines with antisense cyclin D1. Otolaryngol. Head Neck Surg., 119: 593-599, 1998.
39. Kommann, M., Arber, N., and Korc, M. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. J. Clin. Investig., 101: 344-352, 1998.
40. Arber, N., Doki, Y., Han, E. K., Sgambato, A., Zhou, P., Kim, N. H., Delohery, T., Klein, M. G., Holt, P. R., and Weinstein, I. B. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res., 57: 1569-1574, 1997.
41. Zhou, P., Jiang, W., Zhang, Y. J., Kahn, S. M., Schieren, I., Santella, R. M., and Weinstein, I. B. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene, 11: 571-580, 1995.
42. Johnson, L. G. Gene therapy for cystic fibrosis. Chest, 107: 77s-82s, 1995.
43. Dowdy, S. F., Hinds, P. W., Louis, K., Reed, S. I., Arnold, A., and Weinberg, R. A. Physical interactions of the retinoblastoma protein with human cyclins. Cell, 73: 499-511, 1993.
44. Andl, T., Kahn, T., Pfuhl, A., Nicola, T., Erber, R., Conradt, C., Klein, W., Helbig, M., Dietz, A., Weidauer, H., and Bosch, F. X. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res., 58: 5-13, 1998.
45. INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene, 13: 561-568, 1996.
46. 1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdil in p53-mutated human epidermoid carcinoma A431 cells. Cancer Res., 57: 1495-1501, 1997.
47. Li, Y., Pong, R. C., Bergelson, J. M., Hall, M. C., Sagalowsky, A. I., Tseng, C. P., Wang, Z., and Hsieh, J. T. Loss of adenoviral receptor expression in human bladder cells: a potential impact on the efficacy of gene therapy. Cancer Res., 59: 325-330, 1999.
48. Zhang, S-Y., Klein-Szanto, A. J., Sauter, E. R., Shafarenko, M., Mitsunaga, S., Nobori, T., Carson, D. A., Ridge, J. A., and Goodrow, T. L. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res., 54: 5050-5053, 1994.
49. Kaya, S. S., Mahmood, A., Li, Y., Yavuz, E., Goksel, M., and Chopp, M. Apoptosis and expression of p53 response proteins and cyclin D1 after cortical impact in rat brain. Brain Res., 818: 23-33, 1999.
50. Timsit, S., Rivera, S., Ouaghi, P., Guiscard, F., Tremblay, E., Ben-Ari, Y., and Khrestchatisky, M. Increased cyclin D1 in vulnerable neurons in the hippocampus after ischaemia and epilepsy: a modulator of in vivo programmed cell death? Eur. J. Neurosci., 11: 263-278, 1999.
51. Kranenburg, O., van der Eb, A. J., and Zantema, A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J., 15: 46-54, 1996.
52. Kohno, T., Yoshida, S., and Bessho, M. Accelerated entry into S phase associated with up-regulation of cyclin D1 as a mechanism for granulocyte colony-stimulating factor (G-CSF)-induced apoptosis of murine myeloid leukemia cells. Leuk. Res., 22: 257-263, 1998.
53. Weinstein, I. B., Begemann, M., Zhou, P., Han, E. K., Sgambato, A., Doki, Y., Arber, N., Ciaparrone, M., and Yamamoto, H. Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. Clin. Cancer Res., 3: 2696-2702, 1997.
54. Li, J., Hu, S-X., Perng, G-S., Zhou, Y., Xu, K., Zhang, C., Seigne, J., Benedict, W. F., and Xu, H-J. Expression of the retinoblastoma (RB) tumor suppressor gene inhibits tumor cell invasion in vitro. Oncogene, 13: 2379-2386, 1996.